期刊
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
卷 23, 期 2, 页码 194-197出版社
AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/jnp.23.2.jnp194
关键词
-
资金
- NIMH
- NARSAD
- TSA
- OCF
- Wyeth
- Jazz Pharmaceuticals
- Bristol-Myers Squibb
- Medtronic
- Eli Lilly
- Northstar
- McNeil
- Brand Ideas
- Reed Elsevier
- Cyberonics
The safety of electroconvulsive therapy (ECT) in patients with deep brain stimulation (DBS) has not been established. Cases reported had no adverse events, but DBS was withheld throughout the weeks of the ECT course. The authors report the first case of temporary interruption of DBS only during the minutes of each outpatient ECT. (The Journal of Neuropsychiatry and Clinical Neurosciences 2011; 23: 194-197)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据